You are here: Industry Insights > COVID-19

News List

KindredBio Expands Manufacturing Agreement with Vaxart contractpharma
October 15, 2020
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.
U.S. Govt. Selects LabVantage’s LIMS contractpharma
October 15, 2020
Walter Reed Army Research Inst. will use LIMS to support the production of vaccines for COVID-19 and other diseases.
Fujifilm Diosynth to Manufacture Lilly COVID-19 Antibody contractpharma
October 15, 2020
Commercial manufacturing of the antibody therapy is expected to commence in April 2021.
Symbiosis Completes MHRA Regulatory Inspection contractpharma
October 15, 2020
Scottish CMO recorded no critical or major observations from the reinspection by the MHRA.
COVID-19 to influence the outcome of Brexit: Poll pharmaceutical-technology
October 15, 2020
The Brexit transition deadline of 31 December 2020 is fast approaching, but a trade deal between the UK and European Union (EU) is yet to be finalised.
First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine americanpharmaceuticalreview
October 15, 2020
The CoVIg-19 Plasma Alliance, a collaboration of plasma companies supported by organizations outside the plasma industry, confirmed patients are now being enrolled in the Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) ...
Lilly, Incyte Release Information on Baricitinib, Remdesivir Combination for COVID-19 americanpharmaceuticalreview
October 15, 2020
Eli Lilly and Company and Incyte are sharing additional data showing baricitinib in combination with remdesivir reduced time to recovery and improved clinical outcomes for patients with COVID-19 infection compared with remdesivir.
US enters agreement for experimental prophylactic COVID-19 antibody cocktail europeanpharmaceuticalreview
October 15, 2020
The US government will develop and manufacture AstraZeneca’s investigational monoclonal antibody cocktail, AZD7442, a potential prophylactic treatment for COVID-19.
Can an antibody 'cocktail' prevent COVID-19 infection? worldpharmanews
October 15, 2020
In a new clinical trial, UC Davis Health will test the effectiveness and safety of REGN-COV2, the monoclonal antibody cocktail, in preventing COVID-19 in adults living with infected patients.
Regeneron's REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients worldpharmanews
October 15, 2020
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in ...